EVITA TEST COMPLETE is a screening test that examines for chromosomal
abnormalities in the form of aneuploidies in the fetus such as Trisomy 21 (Down
syndrome), and for copy number variations (microdeletions and microduplications).
If chromosomal abnormalities are detected by an EVITA TEST COMPLETE, an invasive
diagnostic test such as Chorionic Villus Sampling (CVS) is always recommended
to verify the finding. A CVS is a diagnostic analysis and is typically offered in pregnancy
weeks 10-12, if there is a risk that the fetus has chromosomal aneuploidies.
The CVS has an even better resolution, as it is based on the analysis of tissue
biopsy, and thus it is possible to find even smaller copy number variations in
the fetus.